Vir Biotechnology, Inc. SEC filings VIR

Vir Biotechnology, Inc. has 801 filings in SEC EDGAR's recent list, going back to Jun 29, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Vir Biotechnology, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 3, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
4 Insider transaction Oct 28, 2026 Oct 27, 2026
3 Initial insider ownership Oct 28, 2026 Oct 27, 2026
8-K Current report
Officer or director change
Oct 28, 2026 Oct 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
8-K Current report
Unregistered share sale, Other events
Oct 14, 2026 Oct 9, 2026
8-K Current report
Other events
Oct 8, 2026 Oct 8, 2026
3 Initial insider ownership Oct 6, 2026 Oct 5, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 1, 2026 Oct 1, 2026
144 Notice of proposed sale Sep 17, 2026 —
144 Notice of proposed sale Sep 9, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 12, 2026 Aug 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
8-K Current report
Officer or director change
Jul 24, 2026 Jul 20, 2026
144 Notice of proposed sale Jun 29, 2026 —
4 Insider transaction Jun 10, 2026 Jun 9, 2026
3 Initial insider ownership Jun 10, 2026 Jun 9, 2026
8-K Current report
Officer or director change
Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 28, 2026 May 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
4 Insider transaction May 4, 2026 May 1, 2026
4 Insider transaction Apr 30, 2026 Apr 29, 2026
144 Notice of proposed sale Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 16, 2026 —
DEF 14A Proxy statement Apr 16, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Apr 10, 2026 Apr 7, 2026
4 Insider transaction Apr 7, 2026 Apr 6, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Apr 2, 2026 Apr 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 24, 2026 Mar 23, 2026
4 Insider transaction Mar 23, 2026 Mar 20, 2026
144 Notice of proposed sale Mar 23, 2026 —
8-K Current report
Officer or director change
Mar 4, 2026 Mar 4, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 3, 2026 —
4 Insider transaction Mar 3, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
8-K Current report
Other events
Mar 2, 2026 Feb 26, 2026
8-K Current report
Material agreement
Feb 26, 2026 Feb 25, 2026
424B5 Prospectus supplement Feb 26, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
424B5 Prospectus supplement Feb 24, 2026 —
S-8 Employee stock plan registration Feb 23, 2026 —
10-K Annual report Feb 23, 2026 Dec 31, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Feb 23, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
4 Insider transaction Feb 3, 2026 Feb 2, 2026
144 Notice of proposed sale Jan 14, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 2, 2026 —
8-K Current report
Material agreement, Other events
Dec 16, 2025 Dec 16, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 18, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 17, 2025 —
4 Insider transaction Nov 7, 2025 Nov 5, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
144 Notice of proposed sale Nov 5, 2025 —
4 Insider transaction Nov 4, 2025 Nov 3, 2025
4 Insider transaction Nov 4, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 3, 2025 —
4 Insider transaction Oct 30, 2025 Oct 28, 2025
4 Insider transaction Oct 28, 2025 Oct 24, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 22, 2025 Oct 20, 2025
144 Notice of proposed sale Oct 21, 2025 —
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 14, 2025 Oct 9, 2025
4 Insider transaction Oct 9, 2025 Oct 7, 2025
4 Insider transaction Oct 7, 2025 Oct 3, 2025
144 Notice of proposed sale Oct 3, 2025 —
4 Insider transaction Oct 2, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 1, 2025 —
4 Insider transaction Sep 3, 2025 Sep 2, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
4 Insider transaction Aug 4, 2025 Aug 1, 2025
8-K Current report
Other events
Jul 24, 2025 Jul 24, 2025
4 Insider transaction Jul 17, 2025 Jul 15, 2025
144 Notice of proposed sale Jul 17, 2025 —
144 Notice of proposed sale Jul 15, 2025 —
4 Insider transaction Jul 2, 2025 Jul 1, 2025
144 Notice of proposed sale Jul 1, 2025 —
144 Notice of proposed sale Jun 11, 2025 —
144 Notice of proposed sale Jun 10, 2025 —
4 Insider transaction Jun 9, 2025 Jun 9, 2025
144 Notice of proposed sale Jun 9, 2025 —
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
144 Notice of proposed sale Jun 2, 2025 —
8-K Current report
Shareholder vote results
May 29, 2025 May 29, 2025
8-K Current report
Other events
May 9, 2025 May 9, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
ARS Annual report to shareholders Apr 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 May 29, 2025
4 Insider transaction Apr 4, 2025 Apr 3, 2025
144 Notice of proposed sale Apr 3, 2025 —
4 Insider transaction Feb 27, 2025 Feb 26, 2025
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
144 Notice of proposed sale Feb 26, 2025 —
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
4 Insider transaction Feb 19, 2025 Feb 18, 2025
144 Notice of proposed sale Feb 18, 2025 —
4 Insider transaction Feb 14, 2025 Feb 13, 2025
144 Notice of proposed sale Feb 13, 2025 —
8-K Current report
Officer or director change
Jan 30, 2025 Jan 24, 2025
4 Insider transaction Jan 8, 2025 Jan 8, 2025
144 Notice of proposed sale Jan 8, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jan 8, 2025 Jan 8, 2025
4 Insider transaction Dec 4, 2024 Dec 2, 2024
144 Notice of proposed sale Dec 2, 2024 —
4 Insider transaction Nov 18, 2024 Nov 15, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
144 Notice of proposed sale Nov 6, 2024 —
4 Insider transaction Nov 5, 2024 Nov 1, 2024
144 Notice of proposed sale Nov 5, 2024 —
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
4 Insider transaction Oct 24, 2024 Oct 23, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2024 —
3 Initial insider ownership Oct 3, 2024 Oct 2, 2024
3 Initial insider ownership Oct 2, 2024 Oct 1, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VIR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1706431

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.